Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June ...

Second quarter 2025 total revenues increased by 26% to US$93.2 million, compared to the second quarter 2024, driven by strong ...

Second quarter 2025 total revenues increased by 26% to US$93.2 million, compared to the second quarter 2024, driven by strong RUCONEST® and Joenja® revenue growthRUCONEST® second quarter revenue incre ...

In a giant feat of genetic engineering, scientists have created bacteria that make proteins in a radically different way than ...

Detailed price information for Cellectis S.A. ADR (CLLS-Q) from The Globe and Mail including charting and trades.

KIOXIA will take center stage at FMS to spotlight how its flash memory and SSD innovations are driving scalable, efficient ...

A large cell of Palestinian resistance fighters ambushed Israeli forces along a military supply route in Khan Yunis, in the ...

The best smart home devices to make your everyday tasks a lot easier. Here are our tested top picks to help you work smarter, not harder.

Fresenius Kabi has licensed rights from Polpharma Biologics to commercialize the vedolizumab biosimilar candidate PB016 globally—except in the ...